NPR Science Friday interview with Dr. Denise Faustman
NPR recently interviewed Dr. Denise Faustman on Science Friday. It's good to see NPR paying attention to this research.She mentions an additional benefit to the Phase 1 trial. Besides validating that BCG has some effect on the bad T-cells that are killing insulin-producing beta cells, it validates that the various new blood tests that they have developed to track the bad T-cells.
She comments on the recent research showing that pancreatic cells can be transformed into islet cells. There's a lot covered in this 12-minute interview, it's worth listening to.
Labels: faustman, interview, NPR
posted by Bernard @ 6:33 AM
2 Comments
Links to this post
